Surrozen, Inc.
NASDAQ:SRZN
11.88 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 4.146 | 0 | 0 | 0 | 12.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.386 | 0.392 | 0.451 | 0.483 | 0.807 | 0.783 | 0.768 | 8.624 | 0.851 | 0.901 | 0.811 | 2.486 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.386 | -0.392 | 3.695 | -0.483 | -0.807 | -0.783 | 11.732 | -8.624 | -0.851 | -0.901 | -0.811 | -2.486 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0.891 | 0 | 0 | 0 | 0.939 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 4.949 | 4.855 | 5.644 | 6.112 | 6.937 | 8.086 | 9.437 | 8.624 | 9.581 | 9.371 | 10.893 | 10.418 | 10.265 | 8.601 | 8.65 | 6.958 | 5.424 | 4.652 |
| General & Administrative Expenses
| 3.714 | 3.883 | 3.589 | 3.572 | 3.338 | 5.299 | 5.232 | 4.981 | 4.491 | 5.122 | 4.102 | 3.287 | 2.395 | 4.43 | 2.186 | 1.683 | 1.545 | 1.709 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 3.714 | 3.883 | 3.589 | 3.572 | 3.338 | 5.299 | 5.232 | 4.981 | 4.491 | 5.122 | 4.102 | 3.287 | 2.395 | 4.43 | 2.186 | 1.683 | 1.545 | 1.709 |
| Other Expenses
| 3.695 | -0.085 | 0.302 | 0.083 | 0.265 | -0.252 | 0.92 | 0.05 | 0.087 | 6.497 | -0.001 | -0.328 | 0.007 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 8.663 | 8.738 | 9.233 | 9.684 | 10.275 | 13.385 | 14.669 | 13.605 | 14.072 | 14.493 | 14.995 | 13.705 | 12.66 | 13.031 | 10.836 | 8.641 | 6.969 | 6.361 |
| Operating Income
| -9.049 | -9.13 | -9.684 | -11.189 | -10.275 | -14.592 | -2.169 | -13.605 | -14.072 | -14.493 | -14.995 | -13.705 | -12.66 | -13.031 | -10.836 | -8.641 | -6.969 | -6.361 |
| Operating Income Ratio
| 0 | 0 | -2.336 | 0 | 0 | 0 | -0.174 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -16.212 | 0.3 | 0.771 | -1.422 | 0.265 | 0.295 | 1.394 | 0.05 | 0.147 | 6.546 | -0.001 | -0.328 | 0.007 | 0.009 | 0.009 | 0.006 | 0.002 | 0.074 |
| Income Before Tax
| -25.261 | -8.83 | -8.913 | -10.445 | -9.387 | -14.297 | -0.775 | -13.357 | -13.925 | -7.947 | -14.954 | -14.019 | -12.653 | -13.022 | -10.827 | -8.635 | -6.967 | -6.287 |
| Income Before Tax Ratio
| 0 | 0 | -2.15 | 0 | 0 | 0 | -0.062 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0.349 | -1.858 | 0.844 | -0.623 | 1.637 | -8.087 | -0.668 | -0.147 | -6.546 | -0.58 | -0.014 | -0.492 | 0 | 0 | -0.451 | 0 | 0 |
| Net Income
| -25.261 | -8.83 | -8.913 | -10.445 | -9.387 | -15.934 | 7.312 | -13.357 | -13.778 | -1.401 | -14.954 | -14.019 | -12.653 | -13.022 | -10.827 | -8.635 | -6.967 | -6.287 |
| Net Income Ratio
| 0 | 0 | -2.15 | 0 | 0 | 0 | 0.585 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -7.99 | -4.24 | -4.32 | -5.14 | -4.68 | -7.97 | 3.65 | -5.73 | -0.39 | -0.04 | -0.61 | -0.51 | -0.36 | -0.37 | -0.31 | -0.25 | -14.28 | -13.39 |
| EPS Diluted
| -7.99 | -4.24 | -4.32 | -5.14 | -4.68 | -7.97 | 3.65 | -5.73 | -0.39 | -0.04 | -0.61 | -0.51 | -0.36 | -0.37 | -0.31 | -0.25 | -14.28 | -13.39 |
| EBITDA
| -8.663 | -8.738 | -9.233 | -7.696 | -9.78 | -12.178 | -2.169 | -13.605 | -13.599 | -13.959 | -14.995 | -13.18 | -12.66 | -12.52 | -10.367 | -8.641 | -6.488 | -5.825 |
| EBITDA Ratio
| 0 | 0 | -2.227 | 0 | 0 | 0 | -0.174 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |